DK2175877T3 - Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme - Google Patents

Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme

Info

Publication number
DK2175877T3
DK2175877T3 DK08786266.0T DK08786266T DK2175877T3 DK 2175877 T3 DK2175877 T3 DK 2175877T3 DK 08786266 T DK08786266 T DK 08786266T DK 2175877 T3 DK2175877 T3 DK 2175877T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
coagulation disorders
mutated antithrombin
antithrombin
Prior art date
Application number
DK08786266.0T
Other languages
English (en)
Inventor
Delphine Borgel-Botbol
Veronique Feger-Picard
Elsa Bianchini
Original Assignee
Univ Paris Sud Xi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Sud Xi filed Critical Univ Paris Sud Xi
Application granted granted Critical
Publication of DK2175877T3 publication Critical patent/DK2175877T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
DK08786266.0T 2007-07-20 2008-07-18 Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme DK2175877T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290913 2007-07-20
PCT/EP2008/059486 WO2009013251A1 (en) 2007-07-20 2008-07-18 Use of mutated antithrombins for treating or preventing coagulation disorders

Publications (1)

Publication Number Publication Date
DK2175877T3 true DK2175877T3 (da) 2012-04-16

Family

ID=39111552

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08786266.0T DK2175877T3 (da) 2007-07-20 2008-07-18 Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme

Country Status (7)

Country Link
US (1) US8741844B2 (da)
EP (1) EP2175877B1 (da)
JP (1) JP2010533684A (da)
AT (1) ATE539764T1 (da)
CA (1) CA2694047C (da)
DK (1) DK2175877T3 (da)
WO (1) WO2009013251A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5764499B2 (ja) * 2009-01-16 2015-08-19 ユニベルシテ パリ サッド １１Ｕｎｉｖｅｒｓｉｔｅ Ｐａｒｉｓ Ｓｕｄ １１ 変異アンチトロンビン、その製造方法及び薬剤としての使用
US20140356377A1 (en) * 2011-08-25 2014-12-04 Umc Utrecht Holding B.V. Compounds for use in boosting coagulation
CA2916421A1 (en) 2013-03-14 2014-09-25 Bayer Healthcare Llc Monoclonal antibodies against antithrombin beta complexed with heparin
GB201322091D0 (en) 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
EP3212794B1 (en) 2014-10-30 2021-04-07 Genzyme Corporation Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
IL259795B2 (en) 2015-12-07 2024-04-01 Genzyme Corp Methods and preparations for the treatment of diseases related to SERPINC1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901917A1 (de) * 1989-01-24 1990-07-26 Behringwerke Ag Mutanten von humanem antithrombin iii
JP3479539B2 (ja) * 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンｉｉｉ変異体
JPH0971600A (ja) * 1995-09-06 1997-03-18 Eisai Co Ltd ヒトアンチトロンビンｉｉｉ 変異体
DE60037513T2 (de) 1999-05-13 2009-02-05 GTC Biotherapeutics, Inc., Framingham Transgene hergestellte antithrombin iii und deren mutanten
JP2007523876A (ja) * 2003-07-17 2007-08-23 スミスクライン・ビーチャム・コーポレイション Ｈｉｔ患者をアルガトロバンを用いて治療する方法

Also Published As

Publication number Publication date
US20100298224A1 (en) 2010-11-25
ATE539764T1 (de) 2012-01-15
CA2694047C (en) 2018-01-30
EP2175877B1 (en) 2012-01-04
CA2694047A1 (en) 2009-01-29
WO2009013251A1 (en) 2009-01-29
JP2010533684A (ja) 2010-10-28
US8741844B2 (en) 2014-06-03
EP2175877A1 (en) 2010-04-21

Similar Documents

Publication Publication Date Title
CY1121203T1 (el) Θεραπευτικες χρησεις της εμπαγλιφλοζινης
IL260117A (en) Use of placental cells to treat diseases, syndromes or conditions of the lungs
AU2018253580A1 (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
CY1118452T1 (el) Ενωσεις και συνθεσεις ως αναστολεις πρωτεϊνικης κινασης
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
WO2009108856A3 (en) Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
RS53124B (en) USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY
BRPI0808775A2 (pt) compostos e composições como moduladores de atividade de gpr119
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
CU20090148A7 (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
AU2011274619A8 (en) miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
MX356210B (es) Formulaciones de polimero acrilico.
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
IT1395519B1 (it) Pezzo composito, nonche' impiego del pezzo composito
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
IN2012DN02471A (da)
DK2175877T3 (da) Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
ECSP099807A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
ZA201402745B (en) Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and the use thereof.
CR20110552A (es) Tratamiento de transtornos resistentes a la insulina